Navigation Links
Summit VetPharm has Identified Two Instances of Diverted Vectra 3D(TM)
Date:2/4/2008

FT. LEE, N.J., Feb. 4 /PRNewswire/ -- This week, Summit VetPharm has identified two instances where its veterinary exclusive Vectra 3D(TM) product has been found on the websites of internet pharmacies, which is in clear violation of the Company's anti-diversion policy.

"I am very disappointed that individuals have willfully violated our anti- diversion contract and placed our product outside the veterinary channel for sale," stated Julia Stephanus, president and CEO of Summit VetPharm. "Vectra 3D and all Summit VetPharm products are exclusively dispensed by licensed veterinarians. We will not tolerate product diversion because it undermines the relationship between veterinarians and pet owners and raises questions about product integrity."

Summit VetPharm swiftly implemented corrective action against the first instance of attempted product diversion which occurred in Arizona. In the case of the second occurrence, we have determined the source to be originating in southern California and Summit VetPharm is aggressively investigating this situation so that it can be rectified as quickly as possible. Utilizing the proprietary Summit VetPharm Bloodhound(TM) track and trace technology, we have been able to pinpoint where the violations have occurred.

"Veterinarians are highly concerned by product diversion of flea and tick as well as other animal health products. Fellow practitioners have expressed their concerns to me and we will fully enforce our anti-diversion policy. One of the core principles upon which our company was founded was the commitment to ensure that our products are developed and made available exclusively through licensed veterinarians. By securing our supply chain, we are able to protect the veterinary professional, maintain authenticity of our products, and enhance the role of veterinarians in the lives of the animals they treat," stated Dr. Albert Ahn, Senior Director of Veterinary Services.

"Through our Bloodhound Technology and our legally-binding anti-diversion agreement, which must be signed by the practice owner prior to a purchase of Vectra 3D, we can keep companion animal health exactly where it belongs -- in the hands of professionals. The terms strictly prohibit the sale of Vectra 3D outside of the veterinary client patient relationship. This agreement explicitly states that sales outside of this relationship will result in legal action against both the identified veterinary diverter as well as any potential reseller of the product. Veterinarian response to the Summit VetPharm anti-diversion policy and the proprietary Bloodhound technology has been overwhelmingly positive," continued Julia Stephanus.

Vectra 3D's new triple-action topical ectoparasiticide formula is available to pet owners only through licensed veterinarians. Vectra 3D is available in four different sizes: for dogs and puppies over 7 weeks of age weighing 2.5 to 20 pounds; 21 to 55 pounds; 56 to 95 pounds, and for dogs over 95 pounds. Vectra 3D is currently available to veterinarians from the following distributors: NLS Animal Health, a division of Henry Schein Inc, Midwest Veterinary Supply, Inc., Merritt Veterinary Supplies, Inc., Associated Medical, Great Western, Northeast Veterinary Supply Company, Victor Medical Company and Sanum Puerto Rico, Inc.

Media Contact: Dr. Albert H. Ahn, Summit VetPharm, 201-242-8409

Summit VetPharm, LLC

Founded by veterinarians and experienced industry professionals, Summit VetPharm is committed to protecting the health and welfare of both companion animals and companion animal veterinary practices. As a wholly-owned subsidiary of the Sumitomo Corporation and part of the Sumitomo Corporation group of companies, Summit VetPharm is backed by a longstanding reputation for values and ethics in business and is dedicated to raising the standards in animal health. Summit VetPharm is headquartered in Fort Lee, New Jersey, USA . For more information, visit Summit VetPharm at http://www.summitvetpharm.com


'/>"/>
SOURCE Summit VetPharm, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
2. Novel Mechanism for Long-Term Learning Identified by Carnegie Mellon Researchers
3. Brain Signature for Cigarette Cravings Identified
4. New Risk Factor for Heart Disease Identified in Very Young Children, According to Study at American Heart Association Scientific Sessions
5. Synvista Therapeutics Highlights New Data Demonstrating the Clinical Benefit of Vitamin E Therapy in Patients Identified on the Basis of Haptoglobin Phenotype Testing
6. Potential Early Warning System for Lung Cancer Identified
7. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
Breaking Medicine News(10 mins):